Résultats de la recherche
10
Tout
Conduit Pharmaceuticals Provides Research and Development Update on Progress for Pipeline Assets AZD1656, AZD5658, and AZD5904
19 mars 2025 08h30 HE
|
Conduit Pharmaceuticals
Conduit Pharmaceuticals Provides Research and Development Update on Progress for Pipeline Assets AZD1656, AZD5658, and AZD5904
Conduit Pharmaceuticals Provides Update on Nasdaq Stock Market Hearing Panel
06 mars 2025 09h35 HE
|
Conduit Pharmaceuticals
Conduit Pharmaceuticals Provides Update on Nasdaq Stock Market Hearing Panel
Conduit Progresses Phase II of its AI Initiative with Sarborg
20 févr. 2025 08h00 HE
|
Conduit Pharmaceuticals
Conduit Progresses Phase II of its AI Initiative with Sarborg
Conduit Pharmaceuticals Partners with Charles River in Clinically Relevant Systemic Lupus Erythematosus Model
13 févr. 2025 08h00 HE
|
Conduit Pharmaceuticals
Conduit Pharmaceuticals Partners with Charles River in Clinically Relevant Systemic Lupus Erythematosus Model
Conduit Pharmaceuticals Announces Debt Repayment and Partial Conversion of Senior Secured Note
11 févr. 2025 09h00 HE
|
Conduit Pharmaceuticals
Conduit Pharmaceuticals Announces Debt Repayment and Partial Conversion of Senior Secured Note
Conduit Pharmaceuticals Transitions to Phase II of Sarborg Collaboration to Support AI-Driven Drug Development
07 févr. 2025 08h00 HE
|
Conduit Pharmaceuticals
Conduit Pharmaceuticals Transitions to Phase II of Sarborg Collaboration to Support AI-Driven Drug Development
Conduit Pharmaceuticals Completes Strategic Review with Sarborg to Map Revolutionizing Drug Development with Artificial Intelligence
28 janv. 2025 05h30 HE
|
Conduit Pharmaceuticals
Conduit Pharmaceuticals Completes Strategic Review with Sarborg to Map Revolutionizing Drug Development with Artificial Intelligence
Conduit Pharmaceuticals Inc. Announces Reverse Stock Split
23 janv. 2025 08h00 HE
|
Conduit Pharmaceuticals
Conduit Pharmaceuticals Inc. Announces Reverse Stock Split
Conduit Pharmaceuticals Partners with Agility Life Sciences to Create Enhanced Formulations for its Autoimmune Pipeline
22 janv. 2025 08h00 HE
|
Conduit Pharmaceuticals
Conduit Pharmaceuticals Partners with Agility Life Sciences to Create Enhanced Formulations for its Autoimmune Pipeline
Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics
12 déc. 2024 07h30 HE
|
Conduit Pharmaceuticals
Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics Approach